PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
-3.65%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$342M
AUM Growth
+$342M
(-23%)
Cap. Flow
-$58.8M
Cap. Flow
% of AUM
-17.22%
Top 10 Holdings %
Top 10 Hldgs %
35.85%
Holding
99
New
15
Increased
34
Reduced
31
Closed
18
Top Buys
| 1 |
Tenet Healthcare
THC
|
$8.53M |
| 2 |
iRhythm Technologies
IRTC
|
$6.61M |
| 3 |
Neurocrine Biosciences
NBIX
|
$5.93M |
| 4 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$4.87M |
| 5 |
Teleflex
TFX
|
$4.44M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$13M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$10.9M |
| 3 |
DexCom
DXCM
|
$10.3M |
| 4 |
Avantor
AVTR
|
$8.43M |
| 5 |
Danaher
DHR
|
$6.42M |
Sector Composition
| 1 | Healthcare | 96.94% |
| 2 | Industrials | 2.69% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Veracyte
VCYT
$2.41B
| $1.67M | 0.49% |
60,651
-1,613
| -3% | -$44.5K |
|
52
AtriCure
ATRC
$1.73B
| $1.66M | 0.48% |
+25,236
| New | +$1.66M |
|
|
AKYA
53
DELISTED
Akoya BioSciences
AKYA
| $1.65M | 0.48% |
150,321
+25,321
| +20% | +$278K |
|
54
Alpha Teknova
TKNO
$227M
| $1.65M | 0.48% |
119,468
+14,260
| +14% | +$197K |
|
55
Sutro Biopharma
STRO
$85.6M
| $1.64M | 0.48% |
199,846
-21,373
| -10% | -$176K |
|
56
Plus Therapeutics
PSTV
$45.7M
| $1.53M | 0.45% |
+1,526,316
| New | +$1.53M |
|
57
Lantheus
LNTH
$3.75B
| $1.4M | 0.41% |
+25,295
| New | +$1.4M |
|
58
Lifecore Biomedical
LFCR
$288M
| $1.34M | 0.39% |
+115,316
| New | +$1.34M |
|
|
CNCE
59
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.27M | 0.37% |
+377,399
| New | +$1.27M |
|
60
TELA Bio
TELA
$65.4M
| $1.26M | 0.37% |
108,504
+4,222
| +4% | +$49.1K |
|
|
MRTX
61
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.25M | 0.37% |
15,236
+2,322
| +18% | +$191K |
|
|
SCTL
62
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.21M | 0.35% |
671,817
+26,142
| +4% | +$47K |
|
|
SIEN
63
DELISTED
Sientra, Inc.
SIEN
| $1.18M | 0.35% |
531,860
+40,167
| +8% | +$89.2K |
|
64
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $1.18M | 0.34% |
118,247
+4,603
| +4% | +$45.7K |
|
|
FMTX
65
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $1.16M | 0.34% |
124,310
+24,310
| +24% | +$226K |
|
|
CTIC
66
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.05M | 0.31% |
+225,000
| New | +$1.05M |
|
67
Axogen
AXGN
$718M
| $1.02M | 0.3% |
128,947
-77,651
| -38% | -$617K |
|
68
AnaptysBio
ANAB
$630M
| $922K | 0.27% |
37,285
+1,452
| +4% | +$35.9K |
|
69
Phathom Pharmaceuticals
PHAT
$843M
| $892K | 0.26% |
65,553
-11,928
| -15% | -$162K |
|
|
ALLK
70
DELISTED
Allakos
ALLK
| $867K | 0.25% |
+152,066
| New | +$867K |
|
71
Zymeworks
ZYME
$1.07B
| $781K | 0.23% |
119,286
+77,661
| +187% | +$508K |
|
|
OPNT
72
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $697K | 0.2% |
32,557
+1,266
| +4% | +$27.1K |
|
73
Mirum Pharmaceuticals
MIRM
$3.75B
| $668K | 0.2% |
+30,354
| New | +$668K |
|
|
SURF
74
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $615K | 0.18% |
209,148
-49,754
| -19% | -$146K |
|
|
BLRX
75
BioLineRX
BLRX
$15.5M
| $463K | 0.14% |
270,665
-157,942
| -37% | -$270K |
|